One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment

American Journal of Ophthalmology

Volumn 156, Issue 4, 2013, Pages

  Munk, Marion R ^a   Kiss, Christopher ^a   Huf, Wolfgang ^b   Sulzbacher, Florian ^a   Roberts, Philipp ^a   Mittermüller, Tamara J ^a   Sacu, Stefan ^a   Simader, Christian ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

AGED; ARTICLE; COHORT ANALYSIS; CONTRAST SENSITIVITY; FOLLOW UP; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; SCOTOMA; TREATMENT DURATION; VISION; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 84884591836     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.05.037     Document Type: Article

References (46)

1. C. Frennesson, U.L. Nilsson, B.B. Peebo, and S.E. Nilsson Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration Acta Ophthalmol 88 4 2010 420 425
2. S.B. Bressler Health maintenance issues of the elderly. Vision: age-related macular degeneration Md Med J 38 2 1989 135 137
3. C.A. Hazel, K.L. Petre, R.A. Armstrong, M.T. Benson, and N.A. Frost Visual function and subjective quality of life compared in subjects with acquired macular disease Invest Ophthalmol Vis Sci 41 6 2000 1309 1315 (Pubitemid 30261852)
4. C.G. Kiss, T. Barisani-Asenbauer, S. Maca, S. Richter-Mueksch, and W. Radner Reading performance of patients with uveitis-associated cystoid macular edema Am J Ophthalmol 142 4 2006 620 624
5. Munk M, Kiss C, Huf W, et al. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function [published online ahead of print]. Retina. doi: 10.1097/IAE.0b013e318285cc0c.
6. M. Parravano, F. Oddone, and M. Tedeschi Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab Retina 29 3 2009 329 334
7. J. Mones, and G.S. Rubin Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration Eye 19 11 2005 1142 1150 (Pubitemid 43118179)
8. E. Stifter, S. Sacu, T. Benesch, and H. Weghaupt Impairment of visual acuity and reading performance and the relationship with cataract type and density Invest Ophthalmol Vis Sci 46 6 2005 2071 2075
9. G.E. Legge, J.A. Ross, L.M. Isenberg, and J.M. LaMay Psychophysics of reading. Clinical predictors of low-vision reading speed Invest Ophthalmol Vis Sci 33 3 1992 677 687
10. G.S. Rubin, S.K. West, and B. Munoz A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project Invest Ophthalmol Vis Sci 38 3 1997 557 568 (Pubitemid 27143125)
11. S. Richter-Mueksch, M. Stur, E. Stifter, and W. Radner Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV Graefes Arch Clin Exp Ophthalmol 244 2 2006 154 162
12. I. Cacho, C.M. Dickinson, H.J. Smith, and R.A. Harper Clinical impairment measures and reading performance in a large age-related macular degeneration group Optom Vis Sci 87 5 2010 344 349
13. M. Roesel, B. Heimes, C. Heinz, A. Henschel, G. Spital, and A. Heiligenhaus Comparison of retinal thickness and fundus-related microperimetry with visual acuity in uveitic macular oedema Acta Ophthalmol 89 6 2011 533 537
14. P.A. Keane, P.J. Patel, and Y. Ouyang Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 51 11 2010 5431 5437
15. E. Hatef, E. Colantuoni, and J. Wang The relationship between macular sensitivity and retinal thickness in eyes with diabetic macular edema Am J Ophthalmol 152 3 2011 400 405.e2
16. F.L. Ferris 3rd, A. Kassoff, G.H. Bresnick, and I. Bailey New visual acuity charts for clinical research Am J Ophthalmol 94 1 1982 91 96 (Pubitemid 12080556)
17. W. Radner, W. Obermayer, S. Richter-Mueksch, U. Willinger, M. Velikay-Parel, and B. Eisenwort The validity and reliability of short German sentences for measuring reading speed Graefes Arch Clin Exp Ophthalmol 240 6 2002 461 467 (Pubitemid 36097067)
18. M.C. Burggraaff, R.M. van Nispen, S. Hoek, D.L. Knol, and G.H. van Rens Feasibility of the Radner Reading Charts in low-vision patients Graefes Arch Clin Exp Ophthalmol 248 11 2010 1631 1637
19. W. Radner, U. Willinger, W. Obermayer, C. Mudrich, M. Velikay-Parel, and B. Eisenwort [A new reading chart for simultaneous determination of reading vision and reading speed] Klin Monbl Augenheilkd 213 3 1998 174 181 (Pubitemid 28460072)
20. M.K. Powers Paper tools for assessing visual function Optom Vis Sci 86 6 2009 613 618
21. F. Prager, S. Michels, C. Simader, W. Geitzenauer, and U. Schmidt-Erfurth Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy Retina 28 5 2008 682 688 (Pubitemid 351655119)
22. K. Kriechbaum, F. Prager, and W. Geitzenauer Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year Ophthalmology 116 12 2009 2415 2421
23. G.Y. Fujii, E. De Juan Jr., M.S. Humayun, J.S. Sunness, T.S. Chang, and J.V. Rossi Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 6 2003 1067 1078 (Pubitemid 37485773)
24. G.Y. Fujii, E. de Juan Jr., J. Sunness, M.S. Humayun, D.J. Pieramici, and T.S. Chang Patient selection for macular translocation surgery using the scanning laser ophthalmoscope Ophthalmology 109 9 2002 1737 1744 (Pubitemid 35006408)
25. C.E. McCulloch, and J.M. Neuhaus Prediction of random effects in linear and generalized linear models under model misspecification Biometrics 67 1 2011 270 279
26. N. Bansback, C. Czoski-Murray, and J. Carlton Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity Qual Life Res 16 3 2007 533 543 (Pubitemid 46363686)
27. P.J. Patel, F.K. Chen, L. Da Cruz, G.S. Rubin, and A. Tufail Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 52 6 2011 3089 3093
28. H.J. Cho, C.G. Kim, and S.J. Yoo Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab Am J Ophthalmol 155 1 2013 118 126.e111
29. U. Chakravarthy, S.P. Harding, and C.A. Rogers Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 7 2012 1399 1411
30. D.F. Martin, M.G. Maguire, G.S. Ying, J.E. Grunwald, S.L. Fine, and G.J. Jaffe Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
31. P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration New Engl J Med 355 14 2006 1419 1431 (Pubitemid 44511557)
32. D.M. Brown, P.K. Kaiser, and M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration New Engl J Med 355 14 2006 1432 1444 (Pubitemid 44511558)
33. R.E. Hogg, and U. Chakravarthy Visual function and dysfunction in early and late age-related maculopathy Prog Retin Eye Res 25 3 2006 249 276 (Pubitemid 43782815)
34. E. Ergun, N. Maar, W. Radner, I. Barbazetto, U. Schmidt-Erfurth, and M. Stur Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration Ophthalmology 110 1 2003 65 69 (Pubitemid 36068728)
35. K. Rayner Eye guidance in reading: fixation locations within words Perception 8 1 1979 21 30 (Pubitemid 9133886)
36. T.T. McMahon, M. Hansen, and M. Viana Fixation characteristics in macular disease. Relationship between saccadic frequency, sequencing, and reading rate Invest Ophthalmol Vis Sci 32 3 1991 567 574
37. S.G. Whittaker, and J. Lovie-Kitchin Visual requirements for reading Optom Vis Sci 70 1 1993 54 65 (Pubitemid 23173546)
38. M.D. Crossland, L.E. Culham, and G.S. Rubin Predicting reading fluency in patients with macular disease Optom Vis Sci 82 1 2005 11 17 (Pubitemid 40144322)
39. E.G. Gonzalez, L. Tarita-Nistor, E.D. Mandelcorn, M. Mandelcorn, and M.J. Steinbach Fixation control before and after treatment for neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 52 7 2011 4208 4213
40. P.J. Rosenfeld, H. Shapiro, L. Tuomi, M. Webster, J. Elledge, and B. Blodi Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 3 2011 523 530
41. S.B. Bloch, M. la Cour, and B. Sander Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment Acta Ophthalmol 91 1 2013 42 47
42. D.S. Boyer, A.N. Antoszyk, C.C. Awh, R.B. Bhisitkul, H. Shapiro, and N.R. Acharya Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2 2007 246 252 (Pubitemid 46172497)
43. M. Munk, C. Kiss, and F. Sulzbacher Short-term progression of wet AMD and correlation with 1-year treatment results Acta Ophthalmol 90 6 2012 e420 e427
44. C.G. Kiss, W. Geitzenauer, C. Simader, G. Gregori, and U. Schmidt-Erfurth Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function Invest Ophthalmol Vis Sci 50 5 2009 2376 2383
45. M. Parravano, F. Oddone, and M. Tedeschi Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results Retina 30 7 2010 1017 1024
46. C. Bellmann, K. Unnebrink, G.S. Rubin, D. Miller, and F.G. Holz Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study Graefes Arch Clin Exp Ophthalmol 241 12 2003 968 974 (Pubitemid 38028890)